PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Mar-2023 epocrates Celebrates Sizable 2022 Growth, Driven by New Design, Tools, and Guidelines to Improve the Clinician Experience Businesswire
02-Mar-2023 Tivic Named to Fast Company’s Annual List of the World’s Most Innovative Companies 2023 In the Medical Device Category Businesswire
02-Mar-2023 Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Businesswire
02-Mar-2023 Tivic Named to Fast Company’s Annual List of the World’s Most Innovative Companies 2023 In the Medical Device Category Businesswire
02-Mar-2023 AIT Worldwide Logistics Expands Global Network, Pharmaceutical Logistics Expertise to South Korea Businesswire
02-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Marathon Digital Holdings, Inc. (MARA) on Behalf of Investors Businesswire
02-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulcrum Therapeutics, Inc. (FULC) on Behalf of Investors Businesswire
02-Mar-2023 Jaclyn Harrison Joins ODL as EVP of HR Businesswire
02-Mar-2023 Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification With AI-driven Drug Discovery Platform Businesswire
02-Mar-2023 n-Lorem Foundation Welcomes New Members, Paul Compton and Neil Shneider, to its Board of Directors Businesswire
02-Mar-2023 TeraPore Technologies Raises $10M to Bring Precision Nanofiltration Solutions to New Markets Businesswire
02-Mar-2023 Merck and AstraZeneca Provide Update on US Regulatory Review of LYNPARZA® (olaparib) for Use in Combination With Abiraterone and Prednisone or Prednisolone for the Treatment of Metastatic Castration-Resistant Prostate Cancer Businesswire
02-Mar-2023 Advantus Health Partners and GE HealthCare Announce Multi-Year Agreement to Expand Access to Healthcare Technology Management Services Businesswire
02-Mar-2023 MyMD Announces U.S. Drug Enforcement Administration (DEA) Determines Supera-CBD™ is not a Controlled Substance or Listed Chemical Businesswire
02-Mar-2023 Triplebar and Umami Meats Initiate Technology Collaboration To Optimize Cell Lines for Sustainable Seafood Businesswire
02-Mar-2023 Silence Therapeutics to Report Fourth Quarter and Full Year 2022 Results on March 15, 2023 Businesswire
02-Mar-2023 Harrow to Announce Fourth Quarter 2022 Financial Results on March 23, 2023 Businesswire
02-Mar-2023 Medidata Drives Diversity in Clinical Trials, Passing 30,000 Studies and 9 Million Participants Businesswire
02-Mar-2023 Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 9, 2023 Businesswire
02-Mar-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire